Wednesday, June 22, 2016
- 12:00pm-1:30pm
-
Evaluation of the surface based measures to discriminate progressive supranuclear palsy from corticobasal syndrome
Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Evidence of striatal dopaminergic dysfunction Sydenham’s chorea in remission with (99m)Tc-TRODAT-1 SPECT
Choreas (non-Huntington's disease) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Executive function and verbal fluency in patients with Parkinson’s disease
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Exploring structural covariance networks of gray matter in Parkinson’s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Exploring the brainstem functions in cervical dystonia
Neurophysiology (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Extensive bilateral basal ganglia and cerebellar calcification in Fahr’s syndrome after thyroidectomy
Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings
Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Factors related to psychotic symptoms in patients with Parkinson’s disease
Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 54
- Next Page»